|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0031740,
umls-concept:C0034493,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0063474,
umls-concept:C0085109,
umls-concept:C0229143,
umls-concept:C1122086,
umls-concept:C1281305,
umls-concept:C1521802,
umls-concept:C1611588
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-23
|
|
pubmed:abstractText |
The new photosensitiser PhotoPoint MV6401, indium chloride methyl pyropheophorbide, was assessed as a possible ocular photodynamic therapy agent in a rat model of experimentally induced corneal neovascularisation and in choriocapillaris closure in the rabbit. Optimal drug and light activation parameters were determined.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-11589879,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-11755871,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-11884872,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-12365909,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-2459642,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-6207137,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-8229470,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-8732580,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-8787014,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-9150524,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-9715492,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-9778412,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15615758-9793949
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0007-1161
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
113-9
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15615758-Animals,
pubmed-meshheading:15615758-Capillaries,
pubmed-meshheading:15615758-Choroid,
pubmed-meshheading:15615758-Corneal Neovascularization,
pubmed-meshheading:15615758-Disease Models, Animal,
pubmed-meshheading:15615758-Dose-Response Relationship, Drug,
pubmed-meshheading:15615758-Female,
pubmed-meshheading:15615758-Fluorescein Angiography,
pubmed-meshheading:15615758-Indium,
pubmed-meshheading:15615758-Injections, Intravenous,
pubmed-meshheading:15615758-Male,
pubmed-meshheading:15615758-Organometallic Compounds,
pubmed-meshheading:15615758-Photochemotherapy,
pubmed-meshheading:15615758-Photosensitizing Agents,
pubmed-meshheading:15615758-Rabbits,
pubmed-meshheading:15615758-Rats,
pubmed-meshheading:15615758-Rats, Sprague-Dawley
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.
|
|
pubmed:affiliation |
Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA. thomasciulla@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
